Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Fusion Pharmaceuticals Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +1 vs. Q1 2021
- Shares held
- 27.5M
- −119.1K (−0.4%) vs. Q1 2021
- Total value
- $221.8M
- −$74.1M (−25.0%) vs. Q1 2021
- New holders
- 5
- 15 more added
- Sold out
- 4
- 6 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Paragon Wealth Strategies, LLC | 18 | $0 | 0.00% | +18 | New |
| American Portfolios Advisors | 30 | $242 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 78 | $1.00K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 300 | $2.00K | 0.00% | 00.0% | Unchanged |
| Point72 Hong Kong Ltd | 240 | $2.00K | 0.00% | 00.0% | Unchanged |
| Penserra Capital Management LLC | 965 | $7.00K | 0.00% | +20+2.1% | Added |
| Royal Bank of Canada | 1,150 | $9.00K | 0.00% | +837+267.4% | Added |
| Simplex Trading, LLC | 1,308 | $10.0K | 0.00% | +1,308 | New |
| Bank Julius Baer & Co. Ltd, Zurich | 1,980 | $16.0K | 0.00% | +1,980 | New |
| JPMorgan Chase & Co | 2,043 | $17.0K | 0.00% | +2,019+8,412.5% | Added |
| Bank of America Corp | 2,325 | $18.0K | 0.00% | −19,298−89.2% | Reduced |
| Citigroup Inc | 2,574 | $21.0K | 0.00% | +1,777+223.0% | Added |
| Tower Research Capital LLC (TRC) | 3,015 | $24.0K | 0.00% | +1,457+93.5% | Added |
| UBS Group AG | 3,825 | $31.0K | 0.00% | +3,825 | New |
| Altfest L J & Co Inc | 10,213 | $83.0K | 0.02% | +74+0.7% | Added |
| DekaBank Deutsche Girozentrale | 13,000 | $104.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 14,180 | $114.0K | 0.00% | +14,180 | New |
| Goldman Sachs Group Inc | 18,221 | $147.0K | 0.00% | +4,149+29.5% | Added |
| Geode Capital Management, LLC | 23,089 | $186.0K | 0.00% | 00.0% | Unchanged |
| AlphaCentric Advisors LLC | 71,500 | $578.0K | 0.16% | +34,500+93.2% | Added |
| Alyeska Investment Group, L.P. | 75,000 | $606.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 76,212 | $615.0K | 0.00% | +41+0.1% | Added |
| Woodline Partners LP | 154,597 | $1.25M | 0.02% | +30,003+24.1% | Added |
| Sio Capital Management, LLC | 266,107 | $2.15M | 0.58% | +16,688+6.7% | Added |
| Victory Capital Management Inc | 269,623 | $2.18M | 0.00% | −16,055−5.6% | Reduced |
| BlackRock Inc. | 470,303 | $3.80M | 0.00% | −337,233−41.8% | Reduced |
| Federated Hermes, Inc. | 597,841 | $4.83M | 0.01% | +32,841+5.8% | Added |
| 1832 Asset Management L.P. | 734,321 | $5.93M | 0.01% | 00.0% | Unchanged |
| Artal Group S.A. | 750,000 | $6.06M | 0.14% | +210,736+39.1% | Added |
| Point72 Asset Management, L.P. | 875,141 | $7.07M | 0.04% | +125,141+16.7% | Added |
| Rock Springs Capital Management LP | 948,327 | $7.66M | 0.15% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12.6M | 4.97% | −20.0% | Reduced |
| Perceptive Advisors LLC | 1,775,167 | $14.3M | 0.19% | −175,000−9.0% | Reduced |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20.6M | 0.15% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,973,744 | $24.0M | 4.99% | −15,900−0.5% | Reduced |
| Canada Pension Plan Investment Board | 3,116,966 | $25.2M | 0.03% | 00.0% | Unchanged |
| FMR LLC | 3,184,209 | $25.7M | 0.00% | +45,821+1.5% | Added |
| OrbiMed Advisors LLC | 3,224,770 | $26.1M | 0.27% | 00.0% | Unchanged |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $29.7M | 3.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 0 | $0 | 0.00% | −36,394−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −25,168−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,726−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,745−100.0% | Sold out |